Author

Donna M. Voeller

National Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Stanley LipkowitziD· 2 shared Yoshimi Endo GreeriD· 2 shared Alexei V. LobanoviD· 1 shared Danny Wangsa· 1 shared Daoud M. MeerzamaniD· 1 shared Darawalee WangsaiD· 1 shared David A. WinkiD· 1 shared David John WisniewskiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Stanley LipkowitzORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition

David John Wisniewski, Donna M. Voeller, Yonit A. Addissie, Sachin Kumar Deshmukh, Sharon Wu, Maryam B. Lustberg, Darawalee Wangsa, Danny Wangsa, Kerstin Heselmeyer‐Haddad, Yoshimi Endo Greer, George W. Sledge, Stanley Lipkowitz

Oncogene · Nov 25, 2025Peer-reviewedCancer Biology

TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers

Manjari Kundu, Yoshimi Endo Greer, Alexei V. Lobanov, Lisa A. Ridnour, Renee Nicole Donahue, Yeap Ng, Shashi Ratnayake, Karley White, Donna M. Voeller, Sarah Weltz, Qingrong Chen, Stephen Lockett, Maggie Cam, Daoud M. Meerzaman, David A. Wink, , Stanley Lipkowitz

This study shows TRAIL treatment of TNBC cells activates the NFKB2 pathway, leading to cytokine production that enhances neutrophil chemotaxis and immune suppression.

Cancer Letters · Apr 6, 2025Peer-reviewedCancer Biology